Pharma Lovenjoel SA
Pharma Lovenjoel reported total assets of 482,586 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Mar 2026).
The score of Pharma Lovenjoel shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets -18 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Lovenjoel's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 30,424 € | ||||
| Equity | 83,201 € | ||||
| Cash | 19,962 € | ||||
| EBITDA | 73,469 € | ||||
| Total assets | 482,586 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 27 Mar 2026
- Year ended 30 Sep 2024filed on 27 Mar 2025
- Year ended 30 Sep 2023filed on 25 Mar 2024
- Year ended 30 Sep 2022filed on 14 Apr 2023
- Year ended 30 Sep 2021filed on 15 Apr 2022
Pharma Lovenjoel's financial analysis
- Solvency17.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Lovenjoel
Pharma Lovenjoel's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.213.355
- VAT number
- BE0479213355
- Peppol
- Registered · 0208:0479213355 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 08 Jan 2003
- Registered office
- 3360 Bierbeek
- Latest accounts
- 2025 · filed on 27 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Lovenjoel (SA) has been based in Bierbeek since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 30,424 € and equity of 83,201 €; its revenue is not published. Its solvency stands at 17.2%, below the median of its sector (44.2%).
Companies similar to Pharma Lovenjoel
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Godelaine Retail sale of pharmaceutical products Ostend · balance sheet 482,444 €
- Internationale Apotheek Retail sale of pharmaceutical products Antwerp · balance sheet 483,003 €
- Audopharma Retail sale of pharmaceutical products De Panne · balance sheet 483,083 €
- Pharmacie Jacques Retail sale of pharmaceutical products Courcelles · balance sheet 485,161 €
- De Maeyer Groot-Bijgaarden Retail sale of pharmaceutical products Dilbeek · balance sheet 479,884 €
- City-Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 478,952 €
- delta SUD PHARMA Retail sale of pharmaceutical products Virton · balance sheet 477,640 €
- Pharmalixhe Retail sale of pharmaceutical products Visé · balance sheet 476,967 €
Frequently asked questions about Pharma Lovenjoel
What is the revenue of Pharma Lovenjoel?
Pharma Lovenjoel files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Lovenjoel?
In Belgium, the VAT number is the company number prefixed with BE: BE0479213355 for Pharma Lovenjoel, if the company is VAT-registered. Its company number (CBE) is 0479.213.355.
Where is the registered office of Pharma Lovenjoel?
According to the CBE register, the registered office of Pharma Lovenjoel is in 3360 Bierbeek.
What is the equity of Pharma Lovenjoel?
At the close of the 2025 financial year, the equity of Pharma Lovenjoel amounts to 83,201 €, a solvency of 17.2% of total assets.
Who manages Pharma Lovenjoel?
The register lists 3 active mandates at Pharma Lovenjoel. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Lovenjoel
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →